Adagio Medical Holdings, Inc. cash flow to debt ratio of -87.39% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Adagio Medical Holdings, Inc.'s free cash flow has increased -37.67% from $-31.11M last year to $-19.39M, signaling increasing performance

Adagio Medical Holdings, Inc.'s debt to equity ratio is -62.65, signaling that the company spent its equity and risk bankruptcy.

Adagio Medical Holdings, Inc.'s debt to equity ratio is -62.65, signaling that the company spent its equity and risk bankruptcy.

Adagio Medical Holdings, Inc. has negative EBITDA, making leverage ratio unreliable

Adagio Medical Holdings, Inc.'s interest coverage ratio is -13.24, which means that the company struggles to meet interest obligations, signaling financial risk.

Adagio Medical Holdings, Inc.'s profit margin has increased (-100.00%) in the last year from -19.99K% to 0.00%, signaling increasing performance

Adagio Medical Holdings, Inc.'s short-term assets of $20.08M exceed its short-term liabilities of $8.23M

Adagio Medical Holdings, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Adagio Medical Holdings, Inc.'s return on equity of -661.85%, is lower than 15.00%, indicating bad performance

Adagio Medical Holdings, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Adagio Medical Holdings, Inc. has insufficient public price history to evaluate earnings stability.

Adagio Medical Holdings, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Adagio Medical Holdings, Inc. has negative free cash flow, indicating cash burn

Adagio Medical Holdings, Inc.'s yearly earnings has increased -53.34% since last year from $-53.76M to $-25.08M, signaling increasing performance

Adagio Medical Holdings, Inc.'s yearly revenue has decreased 100.00% since last year from $269.00K to $0.00, signaling decreasing performance

ROIC -74.66% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Adagio Medical Holdings, Inc.'s 3-year revenue CAGR of -100.00% is negative, indicating declining revenue over the past 3 years

Adagio Medical Holdings, Inc. has insufficient public price history to evaluate revenue consistency.

Adagio Medical Holdings, Inc. has insufficient public price history to evaluate ROE consistency.

Adagio Medical Holdings, Inc. has insufficient data to evaluate this check.

Adagio Medical Holdings, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Adagio Medical Holdings, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Adagio Medical Holdings, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Adagio Medical Holdings, Inc. has insufficient data to evaluate this check.

Adagio Medical Holdings, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Adagio Medical Holdings, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Adagio Medical Holdings, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue